Holen Sie sich die Stockscreener-App
23.88
0.73%
-0.015
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ENOV?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$23.89
Offen:
$23.79
24-Stunden-Volumen:
22,486
Relative Volume:
0.02
Marktkapitalisierung:
$1.36B
Einnahmen:
$2.19B
Nettoeinkommen (Verlust:
$-829.17M
KGV:
-1.6754
EPS:
-14.25
Netto-Cashflow:
$-3.95M
1W Leistung:
-8.05%
1M Leistung:
+4.01%
6M Leistung:
-24.91%
1J Leistung:
-35.64%
1-Tages-Spanne:
$23.57
$23.88
1-Wochen-Bereich:
$22.62
$25.71
52-Wochen-Spanne:
$21.00
$40.70
Enovis Corp Stock (ENOV) Company Profile
Firmenname
Enovis Corp
Sektor
Branche
Telefon
(302) 252-9160
Adresse
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
23.78 | 1.41B | 2.19B | -829.17M | -3.95M | -14.25 |
|
ABT
Abbott Laboratories
|
109.98 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
356.32 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.70 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.78 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.33 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Eingeleitet | BTIG Research | Buy |
| 2024-10-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-06-13 | Eingeleitet | JP Morgan | Neutral |
| 2024-02-13 | Eingeleitet | Stephens | Overweight |
| 2024-01-22 | Eingeleitet | UBS | Buy |
| 2024-01-03 | Eingeleitet | William Blair | Outperform |
| 2023-12-15 | Bestätigt | Needham | Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-06-26 | Eingeleitet | Needham | Buy |
| 2023-05-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-10-11 | Eingeleitet | Goldman | Buy |
| 2022-09-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-09-12 | Eingeleitet | Evercore ISI | Outperform |
| 2022-06-28 | Eingeleitet | Argus | Hold |
| 2022-06-27 | Fortgesetzt | Loop Capital | Buy |
| 2022-06-16 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Enovis Corp Aktie (ENOV) Neueste Nachrichten
Enovis (NYSE:ENOV) Insider Oliver Engert Purchases 750 Shares - MarketBeat
Oliver Engert Buys 1,000 Shares of Enovis (NYSE:ENOV) Stock - MarketBeat
Insider Buying: Oliver Engert Acquires Shares of Enovis Corp (EN - GuruFocus
Unveiling Q4 Financial Results: How Enovis (NYSE:ENOV) Compares With Other Specialty Medical Devices & Supplies Stocks - Bitget
A Look At Enovis (ENOV) Valuation After 2025 Earnings Losses And 2026 Revenue Guidance - simplywall.st
Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & SuppliesSpecialty Stocks - Finviz
Enovis Outperforms Rennova Health in Key Financial Metrics - National Today
One Fund Bet $5 Million on Enovis Stock Last Quarter. Shares Surged 14% Post-Earnings - AOL.com
Aug Macro: Can Enovis Corporation ride the EV waveStop Loss & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Zacks Research Upgrades Enovis (NYSE:ENOV) to Strong-Buy - MarketBeat
Insider Buying: Enovis (NYSE:ENOV) Insider Buys 1,000 Shares of Stock - MarketBeat
Insider Buying: Oliver Engert Acquires Additional Shares of Enovis Corp (ENOV) - GuruFocus
Wall Street Analysts Think Enovis (ENOV) Could Surge 76.62%: Read This Before Placing a Bet - Finviz
Why Enovis (ENOV) Is Up 10.5% After 2025 Losses And 2026 Growth Guidance - simplywall.st
Enovis at 2026 CG Musculoskeletal Conference: Strategic Growth and Innovation - Investing.com Nigeria
ENOV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Enovis (NYSE:ENOV) Insider Purchases $25,500.00 in Stock - MarketBeat
Enovis (ENOV) CAO Oliver Engert buys 1,000 shares in market trade - Stock Titan
Enovis (ENOV) CFO records 720-share tax withholding transaction - Stock Titan
Enovis Corporation (ENOV): Investor Outlook On A Promising 75.8% Potential Upside - DirectorsTalk Interviews
Enovis Corp. Hits Day High with Strong 13.89% Intraday Surge - Markets Mojo
Enovis Outperforms Rennova Health in Financial Comparison - National Today
Enovis Reports Strong Q4 and Full-Year 2025 Results - National Today
Enovis Corporation $ENOV Shares Sold by Royce & Associates LP - MarketBeat
Vanguard Group Inc. Boosts Stock Holdings in Enovis Corporation $ENOV - MarketBeat
A Look At Enovis (ENOV) Valuation After Earnings Beat And Higher 2026 Profit Guidance - simplywall.st
American Century Companies Inc. Sells 258,262 Shares of Enovis Corporation $ENOV - MarketBeat
AI Reliance Raises Operational, Regulatory, and Reputational Risks for Enovis Corporation - The Globe and Mail
Enovis Weighs US$501.3m Impairment Against Nebula Led Organic Growth - simplywall.st
Enovis Corporation (NYSE:ENOV) Q4 2025 Earnings Call Transcript - Insider Monkey
Enovis Reports Strong 2025 Performance, Outlines 2026 Outlook - National Today
Enovis Balances Revenue Growth And New Devices With Goodwill Impairment - Yahoo Finance
Enovis Q4 Earnings Call Highlights - MarketBeat
Enovis Corporation 2025 Q4ResultsEarnings Call Presentation (NYSE:ENOV) 2026-02-27 - Seeking Alpha
Needham Raises Price Target on Enovis to $52 From $49, Keeps Buy Rating - marketscreener.com
Decoding Enovis Corp (ENOV): A Strategic SWOT Insight - GuruFocus
Needham Maintains Enovis Corp(ENOV.US) With Buy Rating, Raises Target Price to $52 - 富途牛牛
Enovis (NYSE:ENOV) Posts Earnings Results, Beats Expectations By $0.14 EPS - MarketBeat
Oliver Engert Net Worth (2026) - GuruFocus
Enovis (ENOV) FY 2025 Loss Of US$9.07 EPS Tests Margin Turnaround Narrative - simplywall.st
Enovis Q4 2025 slides: margin expansion drives earnings beat By Investing.com - Investing.com Australia
Enovis tops profit expectations but revenue falls short - MSN
Needham raises Enovis stock price target to $52 on 2027 estimates - Investing.com Australia
Enovis Corp (ENOV) Q4 2025 Earnings Call Highlights: Strong Orga - GuruFocus
Enovis (ENOV) Receives Revised Price Target from BTIG | ENOV Sto - GuruFocus
Enovis reports Q4 adjusted EPS 95c, consensus 84c - TipRanks
Enovis (NYSE:ENOV) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Why Enovis (ENOV) Stock Is Trading Up Today - Yahoo Finance
Enovis Q4 2025 slides: margin expansion drives earnings beat - Investing.com
Enovis Q4 2025 Earnings Preview: Revenue Growth Forecast at 4.1%News and Statistics - IndexBox
Enovis (NYSE:ENOV) Stock Price Up 13.7% on Strong Earnings - MarketBeat
Finanzdaten der Enovis Corp-Aktie (ENOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):